• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Teva launches generic for Pfizer’s Flector pain patch

March 4, 2019 By Sarah Faulkner

Teva Pharmaceuticals - updated logoTeva (NYSE:TEVA) said last week that it launched a generic version of Pfizer‘s (NYSE:PFE) Flector diclofenac epolamine patch.

Using a nonsteroidal anti-inflammatory drug, the topical patch is designed to treat acute pain due to minor strains, sprains and contusions.

Pfizer’s Flector patch garnered annual sales of $123 million in the U.S. as of Dec. 2018, according to IQVIA.

“The launch of our authorized generic of Flector Patch in the U.S. is an important addition to Teva’s portfolio of over 40 generic pain management medicines,” Brendan O’Grady, EVP & head of Teva’s North America commercial division, said in prepared remarks.

Last month, Teva reported that it expects its generic EpiPen auto-injector to hold 25% of the U.S. market by the end of 2019.

Mylan‘s (NSDQ:MYL) brand-name emergency allergy device has dominated the U.S. market for years. After Mylan faced widespread criticism for the price of its EpiPen product, the company launched its own generic for roughly $300.

Teva launched its generic EpiPen auto-injector in November, but priced the product in line with Mylan’s EpiPen generic.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pain Management, Pharmaceuticals, Wall Street Beat Tagged With: Pfizer Inc., Teva Pharmaceuticals

IN CASE YOU MISSED IT

  • BD stock up on Street-beating preliminary quarterly revenue numbers
  • Locate Bio lands FDA breakthrough nod for bone infection device
  • PerkinElmer to acquire Oxford Immunotec
  • Evonik buys polymers business from Durect Corp.
  • New Croatian notified body designated to European MDR

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS